The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

Sep-09

Endocrinology Oncology Pharmacoepidemiology

AUTHORS : Prof Craig Currie, Cardiff University, The Pharma Research Centre, Cardiff MediCentre, Cardiff CF14 4UJ – Email: currie@cardiff.ac.uk

JOURNAL : Diabetologia

REFERENCE: 52(9):1766-77

DOI : 10.1007/s00125-009-1440-6

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more